Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023 (IMAGE)

Impact Journals LLC

Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023

Caption

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Credit

Copyright © 2026 Rapamycin Press LLC dba Impact Journals Oncotarget ® is a registered trademark of Rapamycin Press LLC Impact Journals ® is a registered trademark of Rapamycin Press LLC RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC

Usage Restrictions

With credit to the original source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.